Article Versions Notes

Sánchez Suárez MDM, Martín Roldán A, Alarcón-Payer C, Rodríguez-Gil MÁ, Poquet-Jornet JE, Puerta Puerta JM, Jiménez Morales A. Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era. Pharmaceutics. 2024; 16(1):55. https://doi.org/10.3390/pharmaceutics16010055

Sánchez Suárez, María Del Mar, Alicia Martín Roldán, Carolina Alarcón-Payer, Miguel Ángel Rodríguez-Gil, Jaime Eduardo Poquet-Jornet, José Manuel Puerta Puerta, and Alberto Jiménez Morales. 2024. "Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era" Pharmaceutics 16, no. 1: 55. https://doi.org/10.3390/pharmaceutics16010055

Sánchez Suárez, M. D. M., Martín Roldán, A., Alarcón-Payer, C., Rodríguez-Gil, M. Á., Poquet-Jornet, J. E., Puerta Puerta, J. M., & Jiménez Morales, A. (2024). Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era. Pharmaceutics, 16(1), 55. https://doi.org/10.3390/pharmaceutics16010055